Department of EpidemiologyRollins School of Public HealthEmory UniversityAtlantaGA.
Immunization Services DivisionCenters for Disease Control and PreventionAtlantaGA.
Hepatology. 2021 Aug;74(2):582-590. doi: 10.1002/hep.31756. Epub 2021 Jul 20.
Since 2013, the national hepatitis C virus (HCV) death rate has steadily declined, but this decline has not been quantified or described on a local level.
We estimated county-level HCV death rates and assessed trends in HCV mortality from 2005 to 2013 and from 2013 to 2017. We used mortality data from the National Vital Statistics System and used a Bayesian multivariate space-time conditional autoregressive model to estimate age-standardized HCV death rates from 2005 through 2017 for 3,115 U.S. counties. Additionally, we estimated county-level, age-standardized rates for persons <40 and 40+ years of age. We used log-linear regression models to estimate the average annual percent change in HCV mortality during periods of interest and compared county-level trends with national trends. Nationally, the age-adjusted HCV death rate peaked in 2013 at 5.20 HCV deaths per 100,000 persons (95% credible interval [CI], 5.12, 5.26) before decreasing to 4.34 per 100,000 persons (95% CI, 4.28, 4.41) in 2017 (average annual percent change = -4.69; 95% CI, -5.01, -4.33). County-level rates revealed heterogeneity in HCV mortality (2017 median rate = 3.6; interdecile range, 2.19, 6.77), with the highest rates being concentrated in the West, Southwest, Appalachia, and northern Florida. Between 2013 and 2017, HCV mortality decreased in 80.0% (n = 2,274) of all U.S. counties with a reliable trend estimate, with 25.8% (n = 803) of all counties experiencing a decrease larger than the national decline.
Although many counties have experienced a shift in HCV mortality trends since 2013, the magnitude and composition of that shift have varied by place. These data provide a better understanding of geographic differences in HCV mortality and can be used by local jurisdictions to evaluate HCV mortality in their areas relative to surrounding areas and the nation.
自 2013 年以来,全国丙型肝炎病毒(HCV)死亡率稳步下降,但这一下降在地方层面尚未量化或描述。
我们估计了县级 HCV 死亡率,并评估了 2005 年至 2013 年和 2013 年至 2017 年 HCV 死亡率的趋势。我们使用国家生命统计系统的死亡率数据,并使用贝叶斯多变量时空条件自回归模型,估计了 2005 年至 2017 年 3115 个美国县的年龄标准化 HCV 死亡率。此外,我们还估计了<40 岁和 40 岁以上人群的县级年龄标准化率。我们使用对数线性回归模型来估计感兴趣期间 HCV 死亡率的平均年变化百分比,并比较了县级趋势与全国趋势。在全国范围内,调整年龄后的 HCV 死亡率在 2013 年达到 5.20 HCV 死亡/每 10 万人(95%可信区间[CI],5.12,5.26)的峰值,然后在 2017 年下降至 4.34 HCV 死亡/每 10 万人(95% CI,4.28,4.41)(平均年变化百分比=-4.69;95% CI,-5.01,-4.33)。县级死亡率显示 HCV 死亡率存在异质性(2017 年中位数率=3.6;四分位间距,2.19,6.77),最高死亡率集中在西部、西南部、阿巴拉契亚和佛罗里达北部。在 2013 年至 2017 年期间,在有可靠趋势估计的所有美国县中,80.0%(n=2274)的 HCV 死亡率下降,其中 25.8%(n=803)的所有县的下降幅度大于全国下降幅度。
尽管自 2013 年以来,许多县的 HCV 死亡率趋势发生了变化,但变化的幅度和构成因地点而异。这些数据提供了对 HCV 死亡率地理差异的更好理解,并可由地方当局用于评估其地区相对于周围地区和全国的 HCV 死亡率。